OXLUMO 94.5 mg/.5mL
lumasiran · INJECTION, SOLUTION · Alnylam Pharmaceuticals, Inc.
No Recall History
Plain English
OXLUMO is a injection, solution containing lumasiran at 94.5 mg/.5mL, taken subcutaneous. Manufactured by Alnylam Pharmaceuticals, Inc..
Key Facts
- Brand Name
- OXLUMO
- Generic Name
- lumasiran
- NDC Code (Product)
71336-1002- Manufacturer
- Alnylam Pharmaceuticals, Inc.
- Strength
- 94.5 mg/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA214103
- Marketing Start
- 11/23/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is OXLUMO used for?
OXLUMO contains lumasiran. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is OXLUMO a controlled substance?
OXLUMO is not classified as a controlled substance by the DEA.
What is the generic name for OXLUMO?
The generic name for OXLUMO is lumasiran. There are no other listed brand versions of lumasiran.
What is the NDC code for OXLUMO 94.5 mg/.5mL?
The NDC (National Drug Code) for OXLUMO 94.5 mg/.5mL is 71336-1002, listed by Alnylam Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)